Skip to main content
Log in

Construction of eukaryotic expression plasmid pEGFP-N1-WWOX and its transient expression in SMMC-7721 cells

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To construct eukaryotic expression plasmid pEGFP-N1-WWOX and transiently express it in SMMC-7721 cells.

Methods

Total mRNA was extracted from normal human liver tissue. RT-PCR was used to amplify the aimed segments WWOX cDNA which was then digested with HindIII and BamHI and inserted into a eukaryotic expression plasmid pEGFP-N1 to construct pEGFP-N1-WWOX. The constructed plasmid was transfected into SMMC-7721 cells by lipofectamine 2000 — mediated transfer method. The expression of WWOX in transfected SMMC-7721 cells was detected 24, 36 and 48 h post-transfection with fluorescence microscope and the expression level of WWOX mRNA in transfected SMMC-7721 cells was assay by using RT-PCR. The change of WWOX expression and cell proliferation rates were detected by immunocytochemistry and MTT methods respectively.

Results

The results showed pEGFP-N1-WWOX was successfully constructed and expressed transiently in SMMC-7721 cells. At 48th hour post-transfection, the number of positive cells was increased significantly and much brighter green fluorescence could be detected, while no green fluorescence was detected in the control group. In SMMC-7721 cells transfected with pEGFP-N1-WWOX a high level of porcine WWOX was detected. WWOX expressed by transfected cells could significantly inhibit the proliferation of SMMC-7721 cells.

Conclusion

pEGFP-N1-WWOX was expressed successfully in SMMC-7721 cells, which suggested that might be used as a new therapeutic method for liver cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bednarek AK, Laflin KJ, Daniel RL, et al. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res, 2000, 60: 2140–2145.

    PubMed  CAS  Google Scholar 

  2. Maitra A, Wistuba II, Washington C, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol, 2001, 159: 119–130.

    PubMed  CAS  Google Scholar 

  3. Bednarek AK, Keck-Waggoner CL, Daniel RL, et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res, 2001, 61: 8068–8073.

    PubMed  CAS  Google Scholar 

  4. Thavathiru E, Ludes-Meyers JH, MacLeod MC, et al. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. Mol Carcinog, 2005, 44: 174–182.

    Article  PubMed  CAS  Google Scholar 

  5. Jin C, Ge L, Ding X, et al. PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction. Biochem Biophys Res Commun, 2006, 341: 784–791.

    Article  PubMed  CAS  Google Scholar 

  6. Vesuna F, Winnard P Jr, Raman V. Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. Anal Biochem, 2005, 342: 345–347.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jilin Yi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, F., Li, X. & Yi, J. Construction of eukaryotic expression plasmid pEGFP-N1-WWOX and its transient expression in SMMC-7721 cells. Chin. -Ger. J. Clin. Oncol. 8, 61–64 (2009). https://doi.org/10.1007/s10330-008-0155-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-008-0155-3

Key words

Navigation